T/CGCPU 006-2023 I phase clinical trial capability evaluation specification
T/CGCPU 006-2023 I phase clinical trial capability evaluation specification
Basic Information
Scope
Main technical content: Foreword Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions, acronyms 3.1 Terms and definitions 3.2 Acronyms 4 Evaluation content 4.1 Phase I clinical trial evaluation content 4.2 Phase I clinical trial capability evaluation 5 Evaluation experts 6 Evaluation process 6.1 Establishment of the evaluation process 6.2 Pre-evaluation workflow 6.3 On-site evaluation process 6.4 Issuance of the evaluation report 7 Result determination 7.1 Determination of clauses in the evaluation content 7.2 Evaluation conclusion Appendix A (Normative) Evaluation content and evaluation grades Appendix B (Normative) Specific requirements for the evaluation expert group References